Ansofaxine Hydrochloride

Vjekoslav Peitl, Darko Vlahović
2020 Archives of Psychiatry Research  
Ansofaxine hydrochloride (LY03005; LPM570065) is a triple reuptake inhibitor that inhibits serotonin, dopamine and norepinephrine reuptake. This novel triple reuptake inhibitor is a carboxylic acid ester prodrug of desvenlafaxine. It is currently under development for the treatment of major depressive disorder - a frequent and heterogeneous disorder induced by a complex pattern of genetic, epigenetic, developmental, and environmental factors.
doi:10.20471/may.2020.57.01.09 fatcat:sawxacveprfbnbt2scdythg7wu